MatsukiyoCocokara & Co (3088) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
6 Jun, 2025Executive summary
Net sales rose 3.8% year-over-year to ¥1,061.6 billion, with operating profit up 8.4% to ¥82.1 billion and profit attributable to owners up 4.4% to ¥54.7 billion, driven by strong cosmetics, duty-free sales, and digital initiatives.
Profitability improved through expense control, higher gross margin, and effective seasonal product strategies, despite upfront investments in human capital and systems.
Store network expanded to 3,499 in Japan and 79 overseas, with notable brand recognition and health management accolades.
Financial highlights
Gross profit up 5.1% to ¥372.2 billion; operating profit margin reached 7.7%; EBITDA up 7.5% to ¥104.7 billion.
Free cash flow reached ¥60.6 billion, up ¥19.9 billion year-over-year; cash flows from operating activities grew to ¥81.5 billion.
Dividend payout ratio increased to 32.9%, with annual dividend per share at ¥44.00 post-split.
Outlook and guidance
FY2025 net sales forecasted at ¥1,100 billion, up 3.6% year-over-year; operating profit projected at ¥85.5 billion, up 4.2%.
Annual dividend for FY2025 planned at ¥46 per share, up ¥2 from FY2024.
Medium-term plan targets ¥1.5 trillion net sales and 12%+ ROE by FY2031, with a 50% dividend payout ratio.
Store openings to be carefully managed amid rising costs, with 130 new stores and 90 closures planned for FY2025.
Focus on differentiation, investment in digital and human capital, and sustainable management.
Latest events from MatsukiyoCocokara & Co
- Sales and profits rose on strong cosmetics and M&A, with stable margins and a higher dividend.3088
Q3 202613 Feb 2026 - Record sales and profits, robust PB and cosmetics growth, and higher shareholder returns.3088
Q2 202621 Nov 2025 - Record-high sales and profits driven by cosmetics and digital growth, with stable outlook.3088
Q1 202513 Aug 2025 - Net sales rose 3.5% YoY, but net profit declined amid share buybacks and weather losses.3088
Q2 202413 Jun 2025 - Sales rose 4.6% year-over-year, but profit declined due to higher SG&A expenses.3088
Q1 202413 Jun 2025 - Sales and profit rose, but net income dipped amid investment and industry competition.3088
Q4 20246 Jun 2025